212 Participants Needed

Fractionated CO2 Laser + Clobetasol for Vulvar Lichen Sclerosus

(VULVIE Trial)

Recruiting at 11 trial locations
AD
MG
SN
Overseen BySilpa Nekkanti
Age: 18+
Sex: Female
Trial Phase: Phase 4
Sponsor: Medstar Health Research Institute
Must be taking: Clobetasol
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests if using a special laser along with a strong anti-inflammatory cream can better treat women with vulvar lichen sclerosus compared to using the laser alone. The laser helps the skin heal by making tiny, controlled injuries, while the cream reduces swelling and itching. Researchers will compare improvements in symptoms and quality of life.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop all current medications, but you cannot use topical corticosteroids on the vulvovaginal area for 2 weeks before starting. If you have genital herpes, you should continue your suppression medication during the study.

Is the combination of Fractionated CO2 Laser and Clobetasol safe for treating vulvar lichen sclerosus?

Studies have shown that both fractionated CO2 laser and clobetasol propionate are generally safe for treating vulvar lichen sclerosus, with evaluations including quality of life and vulvar anatomy. No significant safety concerns were reported in the trials, suggesting these treatments are safe for human use.12345

How does the Fractionated CO2 Laser + Clobetasol treatment differ from other treatments for vulvar lichen sclerosus?

The Fractionated CO2 Laser + Clobetasol treatment is unique because it combines a laser therapy with a topical steroid, offering a dual approach that may enhance effectiveness compared to using a steroid alone. The laser helps improve symptoms that are not fully controlled by steroids, potentially providing better long-term management of the condition.13467

What data supports the effectiveness of the treatment Fractionated CO2 Laser + Clobetasol for Vulvar Lichen Sclerosus?

Research shows that both clobetasol propionate ointment and fractionated CO2 laser therapy are effective in treating vulvar lichen sclerosus. Clobetasol, a strong steroid, helps reduce inflammation and symptoms, while the CO2 laser can improve skin texture and reduce scarring.12347

Are You a Good Fit for This Trial?

This trial is for English or Spanish-speaking women aged 18 and older with diagnosed vulvar lichen sclerosus, who are willing to undergo CO2-laser therapy and use clobetasol ointment. It's not for those with vaginal mesh from pelvic surgery, active genital infections, prior LS treatments like laser or immunomodulators, undiagnosed vulvar lesions, cancer treatments, pregnancy plans or current pregnancy, recent corticosteroid use on the genitals, known allergies to clobetasol propionate, breastfeeding mothers or certain skin conditions.

Inclusion Criteria

I am willing and able to use a 0.05% clobetasol propionate treatment.
I am choosing to have CO2-laser therapy.

Exclusion Criteria

I am allergic or cannot use clobetasol propionate 0.05%.
I have a skin condition that might affect treatment results.
I had surgery with vaginal mesh for pelvic organ prolapse, not including slings or sacrocolpopexy.
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive FxCO2 laser therapy with either clobetasol propionate 0.05% ointment or placebo ointment

5 months
Multiple visits for laser treatments and assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment

4-6 weeks
Final study visit

What Are the Treatments Tested in This Trial?

Interventions

  • Clobetasol Propionate 0.05% Ointment
  • Fractionated CO2-laser
Trial Overview The study tests if combining Fractionated CO2-laser treatment (FxCO2) with a traditional medication (clobetasol propionate ointment) is more effective than FxCO2-laser with placebo in treating vulvar lichen sclerosus. Success is measured by improvement in a quality of life questionnaire score. The study also compares changes in symptoms related to sexual function and self-image between the two groups.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: Clobetasol GroupActive Control2 Interventions
Group II: Placebo GroupPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medstar Health Research Institute

Lead Sponsor

Trials
202
Recruited
187,000+

Society of Gynecologic Surgeons

Collaborator

Trials
1
Recruited
180+

Patty Brisben Foundation For Women's Sexual Health

Collaborator

Trials
7
Recruited
360+

Published Research Related to This Trial

A study involving 40 women with vulvar lichen sclerosus found that fractionated CO2 laser therapy did not significantly improve histopathology scores compared to a sham treatment, indicating it is not an effective standalone treatment for this condition.
The trial was well-designed with a double-blind, randomized, sham-controlled approach, but the results showed no statistically significant difference in treatment outcomes, suggesting that alternative therapies may be needed for managing vulvar lichen sclerosus.
Fractionated Carbon Dioxide Laser for the Treatment of Vulvar Lichen Sclerosus: A Randomized Controlled Trial.Mitchell, L., Goldstein, AT., Heller, D., et al.[2023]

Citations

Clobetasol Compared With Fractionated Carbon Dioxide Laser for Lichen Sclerosus: A Randomized Controlled Trial. [2021]
Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. [2022]
Fractionated Carbon Dioxide Laser for the Treatment of Vulvar Lichen Sclerosus: A Randomized Controlled Trial. [2023]
[Our experience in treating vulvar lichen sclerosus]. [2013]
Vulvar lichen sclerosus: a comparison of the short-term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%. [2015]
Randomized clinical trial with fractional CO2 laser and Clobetasol in the treatment of Vulvar Lichen Sclerosus: a clinic study of feasibility. [2023]
Fractional CO2 laser treatment as adjunctive therapy to topical steroids for managing vulvar lichen sclerosus. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security